Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced a partnership with World...
SOPHiA GENETICS SA (Nasdaq: SOPH), today announced that the Company has published its first Environmental, Social and Governance Impact Summary. The ESG Impact Summary highlights the Company’s policies, ongoing practices, and...
CB Therapeutics, a biotechnology and precision fermentation company focused on using cellular agriculture to produce environmentally-friendly products for human health, has been granted a new patent covering the use of...